Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Effect of Virtual Reality Glasses Applied to Hemodialysis Patients on Vital Signs and Anxiety Level

9 juli 2026 bijgewerkt door: Ankara Yildirim Beyazıt University
This randomized controlled experimental study was conducted to evaluate the effects of virtual reality glasses used during hemodialysis on patients' vital signs and anxiety levels. A total of 56 adult patients receiving hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital were randomly assigned to either an experimental group or a control group. Patients in the experimental group watched a 4K virtual reality nature video with relaxing background music during hemodialysis, while the control group received standard hemodialysis care. Vital signs, pain, anxiety, and satisfaction were assessed to evaluate the effectiveness of the virtual reality intervention.

Studie Overzicht

Gedetailleerde beschrijving

The research was designed and conducted as a randomized controlled experimental study to determine the effects of virtual reality glasses on the vital signs and anxiety levels of hemodialysis patients.

The study population consisted of patients diagnosed with kidney failure who received hemodialysis at Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between May 2023 and May 2024. A total of 56 patients who volunteered to participate and met the inclusion criteria were included in the study. These patients were randomly assigned to two homogeneous groups according to gender and type of renal failure (acute/chronic): an experimental group (n=28) and a control group (n=28).

Patients in the experimental group watched a 4K virtual reality video featuring natural scenery accompanied by relaxing background music through virtual reality glasses during hemodialysis, whereas patients in the control group received standard hemodialysis care without any additional intervention.

Data were collected using the Patient Information Form, Vital Signs Follow-up Form, Visual Analog Scale for Pain (VAS), State Anxiety Scale, and Visual Analog Scale for Satisfaction (VAS-Satisfaction). Ethics committee approval, institutional permission, and written informed consent were obtained before the study was conducted.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

56

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Ankara, Turkije (Türkiye), 06200
        • Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen
  • Oudere volwassene

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Receiving hemodialysis treatment for the first time.
  • Age ≥18 years.
  • No visual, hearing, or cognitive impairment.
  • Able to communicate effectively.
  • Clinically stable.
  • No diagnosed psychiatric disorder or use of psychiatric medication.
  • No history of seizures.
  • Willing and able to provide informed consent.

Exclusion Criteria:

  • Previous hemodialysis treatment.
  • Age <18 years.
  • Visual, hearing, or cognitive impairment.
  • History of kidney transplantation.
  • Communication difficulties.
  • Diagnosed psychiatric disorder or use of psychiatric medication.
  • History of seizures.
  • Declined to participate in the study.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Experimental Group
Participants received a virtual reality intervention during hemodialysis in addition to standard care.
Participants wore virtual reality glasses at the start of the hemodialysis session and viewed a 4K nature video with calming background music for 15 minutes. The intervention was administered once during the hemodialysis session in addition to standard hemodialysis care.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.
Actieve vergelijker: Control Group
Participants received standard hemodialysis care without any additional intervention.
Participants received routine hemodialysis care according to the standard clinical practice of the dialysis unit without any additional intervention.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Systolic Blood Pressure
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in systolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Diastolic Blood Pressure
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in diastolic blood pressure measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Heart Rate
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in heart rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Respiratory Rate
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in respiratory rate measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Peripheral Oxygen Saturation (SpO₂)
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in peripheral oxygen saturation (SpO₂) measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in Body Temperature
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in body temperature measured before and after the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
State Anxiety Level After Hemodialysis
Tijdsspanne: Immediately after completion of the hemodialysis session.
State anxiety measured using the State Anxiety Inventory (STAI-State), a 20-item questionnaire with total scores ranging from 20 to 80. Higher scores indicate greater levels of state anxiety. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Pain Score
Tijdsspanne: Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Change in pain score measured using the Visual Analog Scale for Pain (VAS-P), a 0-10 scale where 0 indicates no pain and 10 indicates the worst possible pain. Higher scores indicate greater pain. Pain was assessed before and immediately after completion of the hemodialysis session.
Baseline (before the hemodialysis session) and immediately after completion of the hemodialysis session.
Participant Satisfaction Score
Tijdsspanne: Immediately after completion of the hemodialysis session.
Participant satisfaction with the virtual reality intervention measured using the Visual Analog Scale for Satisfaction (VAS-S), a 0-10 scale where 0 indicates not satisfied at all and 10 indicates completely satisfied. Higher scores indicate greater participant satisfaction. Assessment was performed immediately after completion of the hemodialysis session.
Immediately after completion of the hemodialysis session.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Studie directeur: Hilal Tüzer, Assoc. Prof., Ankara Yildirim Beyazıt University

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

3 mei 2023

Primaire voltooiing (Werkelijk)

27 mei 2024

Studie voltooiing (Werkelijk)

27 mei 2024

Studieregistratiedata

Eerst ingediend

28 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

9 juli 2026

Eerst geplaatst (Werkelijk)

15 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

15 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

9 juli 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Beschrijving IPD-plan

The decision regarding sharing of individual participant data has not yet been finalized. Any future data sharing will be considered in accordance with institutional policies, ethical requirements, and applicable regulations.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren